Special Issue on Drug and Disease Management
Drug
and Disease Management aims to explore innovative approaches,
emerging research, and best practices in the effective use of pharmacological
and non-pharmacological interventions for managing acute and chronic diseases.
This issue welcomes original research, clinical studies, and reviews that
examine drug efficacy, safety, personalized medicine, treatment adherence, and
integrated care strategies across various health conditions. It also highlights
advancements in therapeutic drug monitoring, health policy, and the role of
interdisciplinary collaboration in optimizing patient outcomes and improving
healthcare delivery.
In this special issue, we intend to invite
front-line researchers and authors to submit original research and review
articles on exploring Drug and Disease Management. Potential topics include, but are not limited to:
-
Biologics and biosimilars
-
Chronic disease management
-
Clinical pharmacology
-
Disease-specific treatment protocols
-
Drug safety and pharmacovigilance
-
Drug utilization review
-
Drug-drug interactions
-
Evidence-based treatment
-
Health outcomes research
-
Integrated care strategies
-
Medication adherence
-
Medication therapy management
-
Pharmacoeconomics
-
Pharmacotherapy
-
Polypharmacy management
-
Rational drug use
-
Remote disease monitoring
-
Therapeutic drug monitoring
Authors should read over the journal’s For Authors carefully before submission. Prospective authors should submit an electronic
copy of their complete manuscript through the journal’s Paper Submission
System.
Please kindly specify the “Special Issue”
under your manuscript title. The research field “Special Issue - Drug
and Disease Management” should be selected during your submission.
Special Issue Timetable:
Submission Deadline
|
October 18th,
2025
|
Publication Date
|
December 2025
|
Guest Editor:
Dr. Marjan Dzeparoski
Associate
Professor, Faculty for Medical Sciences, Stip, Macedonia
Member,
Pharmaceutical Chamber of R. Macedonia, Athens Institute for Education &
Research and European Federation of Biotechnology (EFB), Macedonia
For
further questions or inquiries, please contact Editorial Assistant at jbm@scirp.org.